96 related articles for article (PubMed ID: 14582845)
21. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
22. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
23. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
Lundquist CA; Zhou J; Aiken C
J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
[TBL] [Abstract][Full Text] [Related]
24. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
[TBL] [Abstract][Full Text] [Related]
25. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
26. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
[TBL] [Abstract][Full Text] [Related]
27. The benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10) reduces HIV-1 infectivity in vitro by modifying actin dynamics.
Xu J; Lecanu L; Tan M; Yao W; Greeson J; Papadopoulos V
Antivir Chem Chemother; 2006; 17(6):331-42. PubMed ID: 17249247
[TBL] [Abstract][Full Text] [Related]
28. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.
Balzarini J; Van Laethem K; Daelemans D; Hatse S; Bugatti A; Rusnati M; Igarashi Y; Oki T; Schols D
J Virol; 2007 Jan; 81(1):362-73. PubMed ID: 17050611
[TBL] [Abstract][Full Text] [Related]
29. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
[TBL] [Abstract][Full Text] [Related]
30. [Replication inhibitors targeting early events in the HIV-1 life cycle].
Ichiyama K; Yamamoto N
Nihon Rinsho; 2002 Apr; 60(4):784-9. PubMed ID: 11968789
[TBL] [Abstract][Full Text] [Related]
31. The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression.
Roland J; Berezov A; Greene MI; Murali R; Piatier-Tonneau D; Devaux C; Briant L
DNA Cell Biol; 1999 Nov; 18(11):819-28. PubMed ID: 10595395
[TBL] [Abstract][Full Text] [Related]
32. [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents].
Pokrovskiĭ AG; Pliasunova OA; Gashnikova NM; Mamaeva OA; Fediuk NV
Vopr Virusol; 2001; 46(6):38-42. PubMed ID: 11785387
[TBL] [Abstract][Full Text] [Related]
33. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
34. Phosphorothioate hammerhead ribozymes targeting a conserved sequence in the V3 loop region inhibit HIV-1 entry.
Zhang X; Iwatani Y; Shimayama T; Yamada R; Koito A; Xu Y; Sakai H; Uchiyama T; Hattori T
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):441-50. PubMed ID: 9918108
[TBL] [Abstract][Full Text] [Related]
35. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by AZT of HIV-1 replication in acutely infected U-937 cells.
Boulerice F; Wainberg MA
J Leukoc Biol; 1990 Jun; 47(6):498-505. PubMed ID: 2191063
[TBL] [Abstract][Full Text] [Related]
37. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.
Teixeira C; Gomes JR; Gomes P; Maurel F; Barbault F
Eur J Med Chem; 2011 Apr; 46(4):979-92. PubMed ID: 21345545
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
39. Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
Rivero-Buceta E; Doyagüez EG; Colomer I; Quesada E; Mathys L; Noppen S; Liekens S; Camarasa MJ; Pérez-Pérez MJ; Balzarini J; San-Félix A
Eur J Med Chem; 2015 Dec; 106():34-43. PubMed ID: 26513643
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs.
Kuwasaki T; Hatta M; Takeuchi H; Takaku H
J Antimicrob Chemother; 2003 Apr; 51(4):813-9. PubMed ID: 12654739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]